950210.KS
Prestige BioPharma Limited
KSC · Healthcare · Biotechnology · SG
KRW 6,470.00
−3.72%Margins
Gross margin
-86.1%
EBITDA margin
-273.3%
EBIT margin
-367.7%
Net margin
-383.3%
FCF margin
—
—
Return on equity
—
Return on assets
—
Return on invested capital
—
Asset turnover
—
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026